Autoimmune Disease Diagnostics Market Size Report, 2034

Autoimmune Disease Diagnostics Market - By Product, By Disease Type, By Test Type, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; Disease Type trends

2.2.4&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; High incidence and prevalence of autoimmune diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Growing awareness about autoimmune diseases

3.2.1.3&nbsp;&nbsp;&nbsp; Supportive government policies for research activities on autoimmune diseases

3.2.1.4&nbsp;&nbsp;&nbsp; Technological advancements and increasing adoption of lab automation technologies

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of advanced diagnostic tests

3.2.2.2&nbsp;&nbsp;&nbsp; Slow turnaround time for test results and need for multiple diagnostic tests

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Increasing adoption of AI and machine learning in diagnostics

3.2.3.2&nbsp;&nbsp;&nbsp; Growth in home-based and self-diagnostic kits

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Gap analysis

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

3.9&nbsp;&nbsp;&nbsp; Future market trends

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.3.1&nbsp;&nbsp;&nbsp; Global

4.3.2&nbsp;&nbsp;&nbsp; North America

4.3.3&nbsp;&nbsp;&nbsp; Europe

4.3.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.3.5&nbsp;&nbsp;&nbsp; LAMEA

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Reagents and consumables

5.3&nbsp;&nbsp;&nbsp; Instruments

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Disease Type, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Localized autoimmune disease

6.2.1&nbsp;&nbsp;&nbsp; Type 1 diabetes

6.2.2&nbsp;&nbsp;&nbsp; Inflammatory bowel disease

6.2.3&nbsp;&nbsp;&nbsp; Thyroid

6.2.4&nbsp;&nbsp;&nbsp; Other localized autoimmune diseases

6.3&nbsp;&nbsp;&nbsp; Systemic autoimmune disease

6.3.1&nbsp;&nbsp;&nbsp; Rheumatoid arthritis

6.3.2&nbsp;&nbsp;&nbsp; Systemic lupus erythematosus (SLE)

6.3.3&nbsp;&nbsp;&nbsp; Multiple sclerosis

6.3.4&nbsp;&nbsp;&nbsp; Psoriasis

6.3.5&nbsp;&nbsp;&nbsp; Other systemic autoimmune diseases

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Antinuclear antibody tests

7.3&nbsp;&nbsp;&nbsp; Autoantibody tests

7.4&nbsp;&nbsp;&nbsp; Complete blood count (CBC)

7.5&nbsp;&nbsp;&nbsp; C-reactive protein (CRP)

7.6&nbsp;&nbsp;&nbsp; Urinalysis

7.7&nbsp;&nbsp;&nbsp; Other test types

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Diagnostics centers

8.4&nbsp;&nbsp;&nbsp; Other end use

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott

10.2&nbsp;&nbsp;&nbsp; BIOMERIEUX

10.3&nbsp;&nbsp;&nbsp; BIO-RAD

10.4&nbsp;&nbsp;&nbsp; DIAsource

10.5&nbsp;&nbsp;&nbsp; Euroimmun

10.6&nbsp;&nbsp;&nbsp; GRIFOLS

10.7&nbsp;&nbsp;&nbsp; Hemagen Diagnostics

10.8&nbsp;&nbsp;&nbsp; Inova Diagnostics (Werfen)

10.9&nbsp;&nbsp;&nbsp; Labcorp

10.10&nbsp;&nbsp;&nbsp; Quest Diagnostics

10.11&nbsp;&nbsp;&nbsp; Revvity

10.12&nbsp;&nbsp;&nbsp; Roche

10.13&nbsp;&nbsp;&nbsp; SIEMENS Healthineers

10.14&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

10.15&nbsp;&nbsp;&nbsp; Trinity Biotech 
&nbsp;

Autoimmune Disease Diagnostics Market

Inquiry Before Buying